- Stocks
- Healthcare
- NASDAQ: MEDP

Price (delayed)

$162.43

Market cap

$5.8B

P/E Ratio

39.91

Dividend/share

N/A

EPS

$4.07

Enterprise value

$5.64B

Sector: Healthcare

Industry: Diagnostics & Research

The EPS is up by 46% YoY and by 18% QoQ

The net income has increased by 45% YoY and by 17% from the previous quarter

The P/E is 31% higher than the last 4 quarters average of 30.5 but 20% lower than the 5-year quarterly average of 49.7

The debt has soared by 155% year-on-year and by 4% since the previous quarter

What are the main financial stats of MEDP

Market
Valuations
Earnings

Shares outstanding

35.73M

Market cap

$5.8B

Enterprise value

$5.64B

Price to earnings (P/E)

39.91

Price to book (P/B)

7.21

Price to sales (P/S)

6.25

EV/EBIT

33.54

EV/EBITDA

27.97

EV/Sales

6.09

Revenue

$925.93M

EBIT

$168.23M

EBITDA

$201.68M

Free cash flow

$227.34M

Per share
Balance sheet
Liquidity

EPS

$4.07

Free cash flow per share

$6.38

Book value per share

$22.53

Revenue per share

$25.98

TBVPS

$19.13

Total assets

$1.39B

Total liabilities

$584.9M

Debt

$115.14M

Equity

$805.78M

Working capital

$33.54M

Debt to equity

0.14

Current ratio

1.08

Quick ratio

1

Net debt/EBITDA

-0.81

Margins
Efficiency
Dividend

EBITDA margin

21.8%

Gross margin

30.1%

Net margin

15.7%

Operating margin

18%

Return on assets

11.5%

Return on equity

19%

Return on invested capital

207.4%

Return on capital employed

17.7%

Return on sales

18.2%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Medpace Holdings stock price performed over time

Intraday

2.14%

1 week

1.9%

1 month

17.69%

1 year

61.65%

YTD

16.69%

QTD

16.69%

How have Medpace Holdings's revenue and profit performed over time

Revenue

$925.93M

Gross profit

$278.73M

Operating income

$167.04M

Net income

$145.38M

Gross margin

30.1%

Net margin

15.7%

The net income has increased by 45% YoY and by 17% from the previous quarter

The net margin is up by 34% year-on-year and by 13% since the previous quarter

The operating income has increased by 31% year-on-year and by 13% since the previous quarter

The operating margin has grown by 22% YoY and by 9% from the previous quarter

What is Medpace Holdings's growth rate over time

What is Medpace Holdings stock price valuation

P/E

39.91

P/B

7.21

P/S

6.25

EV/EBIT

33.54

EV/EBITDA

27.97

EV/Sales

6.09

The EPS is up by 46% YoY and by 18% QoQ

The P/E is 31% higher than the last 4 quarters average of 30.5 but 20% lower than the 5-year quarterly average of 49.7

MEDP's price to book (P/B) is 112% higher than its 5-year quarterly average of 3.4 and 50% higher than its last 4 quarters average of 4.8

Medpace Holdings's equity has increased by 11% YoY

MEDP's price to sales (P/S) is 95% more than its 5-year quarterly average of 3.2 and 52% more than its last 4 quarters average of 4.1

MEDP's revenue is up by 8% year-on-year and by 3.3% since the previous quarter

How efficient is Medpace Holdings business performance

MEDP's ROIC has shrunk by 54% YoY and by 16% QoQ

The company's return on equity rose by 28% YoY and by 14% QoQ

The ROS is up by 24% YoY and by 9% QoQ

Medpace Holdings's return on assets has increased by 21% YoY and by 11% QoQ

What is MEDP's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for MEDP.

How did Medpace Holdings financials performed over time

The company's total assets is 138% higher than its total liabilities

The total liabilities has grown by 40% YoY and by 16% from the previous quarter

The company's total assets rose by 22% YoY and by 7% QoQ

The debt is 86% smaller than the equity

The debt has soared by 155% year-on-year and by 4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.